To grab the stroma by the horns: From biology to cancer therapy with mesenchymal stem cells

Ilia A. Droujinine; Mark A Eckert; Weian Zhao

doi:10.18632/oncotarget.1040

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

To grab the stroma by the horns: From biology to cancer therapy with mesenchymal stem cells

Ilia A. Droujinine, Mark A Eckert and Weian Zhao _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2013; 4:651-664. https://doi.org/10.18632/oncotarget.1040

Metrics: PDF 3113 views | HTML 3928 views | ?

Abstract

Ilia A. Droujinine1, Mark A. Eckert2 and Weian Zhao2

1 Department of Genetics, Harvard Medical School, Boston, MA

2 Sue and Bill Gross Stem Cell Research Center, Chao Family Comprehensive Cancer Center, Department of Biomedical Engineering, and Department of Pharmaceutical Sciences, University of California, Irvine, CA

Correspondence:

Weian Zhao, email:

Keywords: mesenchymal stem cells, cell therapy, stroma, microenvironment, tumor associated fibroblasts

Received: May 17, 2013 Accepted: May 28, 2013 Published: May 31, 2013

Abstract

Mesenchymal stem or stromal cells (MSCs) are precursor cells that play important roles in tumorigenesis. MSCs are recruited to tumors from local and distant sources to form part of the tumor microenvironment. MSCs influence tumor progression by interacting with cancer cells, endothelial cells, immune cells, and cancer stem cells, in a context-dependent network. This review aims to synthesize this emerging yet controversial field to identify key questions regarding the mechanisms of MSC mobilization and survival in blood; homing to tumors, metastases, and premetastatic sites; spatiotemporal organization and differentiation; and interaction with immune cells and cancer stem cells.Understanding the fundamental biology underlying mesenchymal stem cell and tumor interactions has the potential to inform our knowledge of cancer initiation and progression as well as lead to novel therapeutics for cancer. Furthermore, knowledge of endogenous mechanisms can be used to “program” exogenous MSCs for targeted chemotherapeutic delivery to tumors and metastases. Emerging studies will provide crucial insight into the mechanisms of tumor interactions with the whole organism including MSCs.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 1040

Publication Alerts

Post-Publication Promotion

Publication Discount

Reviews:

To grab the stroma by the horns: From biology to cancer therapy with mesenchymal stem cells

Abstract